We have developed a specific Haemophilus influenzae quantitative PCR (qPCR) that also identifies fucose-negative and protein D-negative strains. Analysis of 100 H. influenzae isolates, 28 Haemophilus haemolyticus isolates, and 14 other bacterial species revealed 100% sensitivity (95% confidence interval [CI], 96% to 100%) and 100% specificity (95% CI, 92% to 100%) for this assay. The evaluation of 80 clinical specimens demonstrated a strong correlation between semiquantitative culture and the qPCR (P < 0.001).
The purpose of this study was to develop a specific quantitative PCR (qPCR) assay to quantify H. influenzae in nasopharyngeal swabs (NPS) and middle ear effusions (MEE) for use in future otitis media studies, including the assessment of the impact of immunization with PHiD-CV on NTHi carriage and disease. For this, we have duplexed the fucP and hpd#3 gene targets to give an H. influenzae-specific qPCR that also detects variant fucP-or hpdnegative strains.
Specific primers and probes were used to amplify a 68-bp fragment of the fucP gene and a 151-bp fragment of the hpd gene in H. influenzae (Table 1) . Both primers were previously described for single-plex qPCRs (16, 20) ; however, probes were modified for compatibility in the duplex assay (Table 1) . Real-time qPCR was conducted on the CFX96 real-time PCR detection system (BioRad, CA, USA). The reaction mix consisted of 5 l of 2ϫ SensiMix II Probe No-ROX (Bioline, Alexandria, NSW, Australia), 1,000 nM each primer and probe (Integrated DNA Technologies, Baulkham Hill, NSW, Australia) diluted in molecular-grade water (Sigma-Aldrich, Castle Hill, NSW, Australia), and 1 l of sample, to a total volume of 10 l. Cycling conditions were 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. A standard curve was generated for each run using serial dilutions of genomic DNA (2000 pg to 0.02 pg) from the reference strain NTHi 86-028NP, originally isolated from the nasopharynx of a child with otitis media (27, 28) . All samples were run in duplicate. The duplex fucP/hpd#3 qPCR assay consistently had an efficiency of 90 to 110% and a limit of quantification (LOQ) of 0.0125 pg for fucP and hpd#3, which is equivalent to 6 copies of H. influenzae DNA (corresponding to a limit of detection of a quantification cycle [ (17), fucP PCR, or wholegenome sequencing (20) . The bacterial isolates were cultured on suitable plate media for 24 h, and then 2 to 3 colonies were resuspended into 200 l of RNase-free water (Sigma-Aldrich) and prepared as colony boils as previously described (17) . The colony boils were diluted 1:10 in RNase-free water for use in the PCR assay. Of the 94 clinical NTHi isolates identified using standard microbiology techniques, 41 were isolated from NPS (30), 15 from MEE (30), 33 from blood, 1 from cerebrospinal fluid, and 4 from unknown clinical sites (kindly supplied by Daniel J. Morton).
Genomic DNA preparations from 80 clinical specimens (67 NPS and 13 MEE), of which 57 were culture positive for NTHi, were evaluated to compare H. influenzae quantification using the duplex fucP/hpd#3 qPCR assay with culture results (see Table 3 ). Collection, storage, and culture of the NPS and MEE used in this study have been described (30) . Prior to DNA extraction, the specimens were thawed, vortexed thoroughly for 30 s, and centrifuged at 13,000 ϫ g in DNA IQ spin baskets (Promega) to ensure maximum DNA recovery. The swabs were then removed from the NPS specimens, and the remaining material was centrifuged at 13,000 ϫ g for 7 min. The supernatant was discarded, and DNA was extracted from the pellet using enzymatic extraction and the QIAamp DNA minikit (Qiagen) as previously described (31) .
The duplex fucP/hpd#3 qPCR was found to be 100% sensitive (95% CI, 96% to 100%), with all of the 100 H. influenzae isolates positive for at least one of the two genes (Table 2 ). When individual targets only were assessed, 83% of the H. influenzae isolates were positive for fucP and 99% were positive for the hpd gene ( Table 2 ). Calculation of the specificity of the duplex fucP/hpd#3 qPCR was based on the 44 non-H. influenzae strains, where all 44 isolates were negative for both target genes, demonstrating 100% specificity (95% CI, 92% to 100%) for H. influenzae detection ( Table 2) .
Of the 57 culture-positive specimens, 55 were positive in the fucP/hpd#3 qPCR assay (Table 3) . Of the 23 specimens that were culture negative, 2 were positive by the fucP/hpd#3 qPCR. Assuming culture to be the current gold standard for NTHi detection, the sensitivity of the fucP/hpd#3 duplex assay for NTHi detection in clinical specimens was 96% (95% CI, 88% to 100%), and the specificity was 91% (95% CI, 72% to 99%). When a specimen was positive for both qPCR targets, the geometric mean DNA concentrations (picograms per milliliter) for fucP and hpd#3 were calculated (although the DNA concentrations were usually similar for both targets). If one target gene was below the LOQ, thus indicating a fucP-or hpd#3-negative strain, then the quantity of H. influ- enzae in the sample was based on the positive gene only. The cultures for 79/80 specimens were semiquantitatively scored as ϩ, ϩϩ, and ϩϩϩ, which corresponded to Ͻ10 3 , 10 3 to 10 4 , and Ն10 4 CFU/ml. A strong correlation between NTHi densities determined by duplex qPCR and semiquantitative culture of the specimens was observed, as determined by the Spearman rho (r ϭ 0.825; P Ͻ 0.001).
Within the 57 H. influenzae qPCR-positive specimens, 5 (9%) were negative for the fucP gene and 4 (7%) were negative for the hpd gene (all from NPS specimens). Duplex qPCR analysis of "culture-defined" NTHi isolates from 8 of the 9 specimens (1 was culture negative) identified to contain variant H. influenzae strains revealed a 50% concordance between isolate identification and specimen identification, with isolates from 3 out of 5 specimens identified as fucP-negative NTHi and 1 out of 3 specimens as hpdnegative NTHi. This concordance would probably increase if Ͼ2 isolates were examined per specimen. Molecular analysis of 2 culture-defined NTHi isolates from each of the 2 culture-positive (Ͻ10 3 CFU/ml) but qPCR-negative specimens confirmed that the isolates were H. influenzae and both targets were present. It is surprising that the qPCR did not identify H. influenzae in these 2 specimens, but possibly the H. influenzae density was very low. The 2 culture-negative/qPCR-positive specimens were from children who were currently taking or had recently received antibiotics.
As the duplex qPCR can distinguish variant H. influenzae strains within clinical specimens, it is suitable for use in determining the frequency at which fucose-negative and protein D-negative H. influenzae strains occur within populations. Such an assay is useful for determining the clinical relevance of these variant strains and, in the case of the hpd-negative isolates, for determining whether there is selective pressure from the PHiD-CV vaccine.
Development of a rapid and reliable method for distinguishing H. influenzae from related species is important for surveillance and diagnosis of H. influenzae disease. A single-target PCR assay cannot reliably identify H. influenzae. We have therefore developed a duplex fucP/hpd#3 qPCR assay with high sensitivity and specificity that can accurately quantify H. influenzae in clinical samples. This fucP/hpd#3 qPCR has the potential to play an important role in clinical diagnostics and carriage surveillance of H. influenzae in addition to evaluation of preventative therapies for NTHi disease.
